![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 13, 9239-9243, March 31, 2000
From the Institut für Biochemische Pharmakologie,
Peter-Mayr-Strasse 1, Innsbruck A-6020, Austria, and the
§ Clinical Molecular Biology Laboratory, Hospitale San
Raffaele, Milan 20132, Italy
Missense mutations in the pore-forming human
Voltage-gated P/Q-type Ca2+ channels are expressed on
cell bodies and dendrites of cerebellar Purkinje cells and other
neurons (1-3) where they are thought to control neuronal excitability, gene expression, neuronal plasticity, and differentiation. These channels are also expressed on presynaptic terminals (3) mediating depolarization-induced Ca2+ influx tightly coupled to
neurotransmitter release (4). The Ca2+-selective pore of
P/Q-type Ca2+ channels is formed by P/Q-type Ca2+ channels have received much attention
recently because CACNA1A mutations have been described which
are responsible for at least three different neurological human
diseases: episodic ataxia type 2 (EA-2),1 spinocerebellar
ataxia type 6, and familial hemiplegic migraine (FHM) with and without
cerebellar ataxia. These mutations may provide important insight into
how altered Ca2+ signaling and neuronal excitability can
lead to neurodegeneration and episodic neurological diseases such as migraine.
Four nonsense mutations (6-8), three splice site mutations, and four
deletions in CACNA1A (5, 7) have been found to segregate in
patients with EA-2. Small CAG expansions were observed in a large
series of patients with spinocerebellar ataxia type 6 (9), and a
further CACNA1A missense mutation was identified in a
patient with severe progressive ataxia (10). At least seven missense
mutations have been identified in families with FHM (5, 11-13).
Defects in the The mechanisms by which these mutations cause these abnormal phenotypes
is unclear. Mutations causing EA-2, an autosomal dominant disease, are
predicted to give rise to truncated, presumably nonfunctional In contrast, we (16) and others (17) have shown recently that
Essentially the same changes in gating kinetics were reported by Hans
et al. (17) after introduction of the same FHM mutations in
human In the current study we examined the functional effects of three
recently published FHM mutations, R583Q, D715E, and V1457L (11-13) to
address further the important questions of whether all FHM mutations
yield functional Ca2+ channels and if altered channel
gating represents a key pathophysiological principle in FHM as
proposed from initial studies.
Mutant
Single mutants R583Q and D715E were constructed according to the
previously described procedure for generation of single mutants T666M
and V714A (16).
Mutation V1457L (corresponding to V1465L in rabbit
All polymerase chain reaction-generated fragments were sequenced
completely to confirm sequence integrity.
Expression of Electrophysiological Recordings--
Inward Ba2+
currents (IBa) through expressed channel complexes were
measured using the two-microelectrode voltage clamp technique as
described previously (21). Similar current amplitudes were obtained
with mutant and wild-type
Recordings were carried out at room temperature in a bath solution
containing 40 mM Ba(OH)2, 50 mM
NaOH, 2 mM CsOH, 5 mM HEPES, adjusted to a pH
of 7.4 with methanesulfonic acid. Voltage recording and current
injecting microelectrodes were filled with 2.8 M CsCl, 0.2 M CsOH, 10 mM EGTA, 10 mM HEPES
(adjusted to pH 7.4 with HCl) and had resistances of 0.3-2 megohm.
Recovery of IBa from inactivation was studied using a
double-pulse protocol. After a 3-s depolarizing prepulse to +10 mV
(holding potential
The voltage dependence of inactivation (steady-state inactivation) was
determined from normalized inward currents elicited during steps to +10
mV after 10-s steps to various holding potentials. The voltage
dependence of activation was determined from I-V curves obtained by
step depolarizations from a holding potential of Data Analysis--
Nonlinear least square fitting and
statistical calculations were performed using OriginR 5.0 (Microcal). Data are given as means ± S.E. for the indicated number of experiments.
Mutations R583Q, D715E, and V1457L, illustrated in Fig.
1A, are located in highly
conserved and functionally important regions of the human
The potential for half-maximal activation (V0.5,act) was
significantly (p < 0.01) shifted to hyperpolarized
potentials for all three mutants without changing the steepness of the
steady-state activation curve (Table I).
This effect was most pronounced in D715E. The midpoint voltage for
steady-state inactivation was not altered in mutant V1457L, but a
significant shift to more negative potentials occurred in R583Q and
D715E (Table I). Apparent reversal potentials were similar for all
constructs (53-59 mV) ruling out major changes in Ba2+
permeability.
Three New Familial Hemiplegic Migraine Mutants Affect P/Q-type
Ca2+ Channel Kinetics*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1A subunit of neuronal P/Q-type Ca2+
channels are associated with familial hemiplegic migraine. We studied
the functional consequences on P/Q-type Ca2+ channel
function of three recently identified mutations, R583Q, D715E, and
V1457L after introduction into rabbit
1A and expression in Xenopus laevis oocytes. The potential for half-maximal
channel activation of Ba2+ inward currents was shifted
by > 9 mV to more negative potentials in all three mutants. The
potential for half-maximal channel inactivation was shifted by > 7 mV in the same direction in R583Q and D715E. Biexponential current
inactivation during 3-s test pulses was significantly faster in D715E
and slower in V1457L than in wild type. Mutations R583Q and V1457L
delayed the time course of recovery from channel inactivation. The
decrease of peak current through R583Q (30.2%) and D715E (30.1%) but
not V1457L (18.7%) was more pronounced during 1-Hz trains of 15 100-ms
pulses than in wild type (18.2%). Our data demonstrate that the
mutations R583Q, D715E, and V1457L, like the previously reported
mutations T666M, V714A, and I1819L, affect P/Q-type Ca2+
channel gating. We therefore propose that altered channel gating represents a common pathophysiological mechanism in familial hemiplegic migraine.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1A
subunits, which also contain the voltage sensors.
1A is
encoded by the human gene CACNA1A on chromosome 19p13
(5).
1A gene are also responsible for the
phenotypes (absence epilepsy and ataxia) of tottering (tg)
and leaner (tgla) mutant mice (14) and may also
occur in more common forms of migraine (15).
1A proteins.2
This must result in a partial loss of P/Q-type Ca2+ channel function.
1A missense mutations causing FHM do not prevent channel activity. FHM is a rare autosomal dominant form of migraine with aura,
associated with ictal hemiparesis and, in some families, with
cerebellar ataxia and atrophy (18). Functional expression of rabbit
1A subunits containing the FHM mutations T666M, V714A, and I1811L revealed mutation-induced changes in gating kinetics altering the extent to which P/Q-type channels accumulate in
inactivation during trains of depolarizing pulses. We therefore
proposed that this could alter Ca2+ influx and signaling
during episodes of high neuronal activity. This in turn might result in
a long term activation of neurons within the proposed "migraine
generator" in the brainstem discovered by brain imaging in migraine
patients (19).
1A followed by heterologous expression in human
embryonic kidney 293 cells and patch clamp analysis. In addition, they
reported mutation-induced changes in single channel kinetics and
expression density.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1A cDNAs--
Mutations were
introduced into rabbit class A Ca2+ channel
1A cDNA (BI-II, 1) by applying the "gene-SOEing"
technique (20) as described previously (21). Nucleotide positions of
endonuclease restriction sites are given in parentheses.
1A mutants were cloned into the polyadenylating
transcription plasmids pSPCBI-2 (1) or pNKS2 (a gift of O. Pongs).
1A,
see legend to Fig. 1) as well as a silent mutation (codon for rabbit Asp-1545 GAC to GAT) were introduced simultaneously into rabbit class A
cDNA by polymerase chain reaction to yield a ClaI
restriction sequence. The mutated polymerase chain reaction fragment
was cut SfiI (4290)-ClaI* (4925) and coligated
with a NheI (3543)-SfiI (4290) fragment of BI-II
into AL20 NheI (3543)-ClaI (homologous position
to ClaI*) (22) to yield complete rabbit
1A
cDNA sequence.
1A Mutants in Xenopus laevis
Oocytes--
Preparation of stage V-VI oocytes from X. laevis and injection of cRNA are described in detail elsewhere
(21). Capped run-off poly(A)+ cRNA transcripts from
XbaI-linearized cDNA templates were synthesized according to the procedures of Krieg and Melton (23).
1
cRNAs were coinjected with
1a (24) and
2-
(25) subunit cRNAs. To exclude effects of
endogenous Ca2+-activated Cl
currents on
current kinetics, experiments were carried out in oocytes previously
injected with 50-100 nl of a 0.1 M BAPTA solution.
1A subunits. Oocytes
expressing peak IBa smaller than 400 nA or larger than 1.8 µA were excluded from analysis. Data analysis and acquisition were
performed by using the pClamp software package (version 6.0, Axon Instruments).
80 mV) the time course of IBa recovery
was determined at
60 mV by applying 300-ms test pulses to +10 mV at
various time intervals after the prepulse. Peak IBa was
normalized to the peak current amplitude measured during the prepulse.
IBa was then allowed to recover for 1 min at
100 mV. This
double-pulse protocol was repeated individually for each recovery time
interval in the same oocyte.
80 mV to various
test potentials. The half-maximal voltage for activation (V0.5,act), the slope factor of the curve at
V0.5,act (kact,), the half-maximal
voltage for steady-state inactivation
(V0.5,inact), and the slope factor of the curve
(kinact) were obtained by fitting the data to
the Boltzmann equation. Apparent reversal potentials were calculated by
extrapolation from I-V relationships.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1A subunit of neuronal P/Q-type Ca2+
channels. Mutation R583Q neutralizes a positive charge in transmembrane segment S4 of the channel in domain II (IIS4). S4 segments form part of
the voltage sensor of voltage-gated Ca2+ channels (26).
D715E is located in IIS6 adjacent to mutation V714A analyzed in our
previous study and V1457L in the S5-S6 linker of domain III. Segments
S5 and S6 and their connecting linkers are assumed to form the pore of
the channel (26). We introduced the single mutations into the
corresponding positions of the highly homologous rabbit
1A subunit (wild type, Ref. 1) and analyzed mutant
channels for changes in their biophysical properties after functional
expression in X. laevis oocytes (together with accessory
1 and
2-
subunits) using the
two-microelectrode voltage clamp technique.

View larger version (33K):
[in a new window]
Fig. 1.
FHM mutations alter Ca2+ current
kinetics. Panel A, proposed folding structure of
Ca2+ channel
1 subunits. The approximate
positions of the new identified FHM mutations are indicated by
black circles, previously reported FHM mutations (16) by
open circles. Human mutation V1457L corresponds to V1465L in
rabbit
1A. Panel B, IBa elicited
by 3-s depolarizations from a holding potential of
80 mV to a test
potential of +10 mV. Traces were normalized to the peak current
amplitude. Normalized representative current traces are shown (cells:
wild type (WT), R7813001; R583Q, R0804046; D715E, R0508006;
V1457L, R3103030). Traces were fitted to a biexponential decay yielding
the following time constants for the fast (
fast) and
slow (
slow) component: wild type: 0.222, 0.897 s; R583Q:
0.205, 0.779 s; D715E: 0.141, 0.564 s; V1457L: 0.252, 1.255 s.
Panel C, effect of mutations on
fast and
slow.
was calculated as in panel B. Data
are the means ± S.E. for n = 5-20. Statistical
significance (p < 0.01) is indicated by
asterisks.
fast: wild type, 0.228 ± 0.014 s; R583Q, 0.197 ± 0.008 s; D715E, 0.142 ± 0.004 s;
V1457L, 0.252 ± 0.007 s.
slow: wild type,
0.806 ± 0.077 s; R583Q, 0.789 ± 0.017 s; D715E, 0.578 ± 0.008 s; V1457L, 1.229 ± 0.034 s.
Effects of mutations on activation and inactivation properties
To investigate whether the FHM mutations affect the time course of
channel inactivation we analyzed the current decay during 3-s test
pulses elicited from a holding potential of
80 mV to +10 mV (Fig.
1B). For wild-type and mutant channels the time course of
inactivation could be well described by a double-exponential function.
D715E significantly (p < 0.01) accelerated both the time constant for the initial fast component (
fast = 0.142 ± 0.004 s, n = 15) and the slow component
(
slow = 0.577 ± 0.008 s, n = 15)
of current decay compared with wild type (
fast = 0.227 ± 0.013 s;
slow = 0.806 ± 0.076 s,
n = 5) (Fig. 1C). Mutation V1457L increased
the time constant for the slow component of the current decay
(
slow = 1.2 ± 0.033 s, n = 11). In
R583Q
fast was also slightly accelerated, but this did
not reach the level of statistical significance. The contribution of
the fast component (wild type: 43.8 ± 2.0%, n = 5) was increased significantly in D715E (57.8 ± 1.5%,
n = 14; p < 0.01) and decreased in
V1457L (27.4 ± 2.3%, n = 10, p < 0.01).
Next we tested whether the mutations also change the extent of peak
IBa decrease during pulse trains which reflects
accumulation of channels in inactivation. Application of 15 100-ms
pulses from a holding potential of
60 mV to a test potential of +10
mV at a frequency of 1 Hz caused a significant (p < 0.01) increase of accumulation in inactivation for mutants R583Q and
D715E but not V1457L. Current decay after 15 pulses was 1.6-fold larger
in R583Q (30.2 ± 0.8%; n = 35) and D715E
(30.1 ± 1.5%; n = 18) than in wild type
(19.1 ± 1%; n = 19) (Fig.
2, A and B).
|
The fraction of channels inactivating during frequent depolarizations
not only depends on the inactivation rate during the pulses but also on
the rate of recovery from inactivation between pulses. Therefore
recovery from inactivation was measured employing a double-pulse
protocol (Fig. 3A). Channels
were inactivated by a 3-s conditioning prepulse from
80 to +10 mV.
The time course of recovery was then determined at
60 mV by applying
300-ms test pulses to +10 mV after various time intervals after the
prepulse (Fig. 3A). Between single double-pulse experiments
the oocytes were held at
100 mV for 60 s to allow full recovery
of IBa. Recovery was determined at
60 mV to maximize the
difference between wild-type and mutant channels. In wild-type and
mutant channels about 90% of IBa recovered after 20 s. In all constructs recovery of IBa followed a
biexponential time course (Fig. 3B). In both R583Q and
V1457L the fraction of recovered current at all time intervals measured
was significantly smaller (p < 0.01) than in wild
type. No change was observed for D715E (Fig. 3B).
|
In summary, our experiments convincingly show that all newly discovered
1A mutations in patients with FHM cause abnormal gating
behavior of P/Q-type Ca2+ channels. Gating changes
therefore seem to represent an elementary mechanism underlying P/Q-type
Ca2+ channel dysfunction in FHM.
| |
DISCUSSION |
|---|
|
|
|---|
We have studied the functional consequences of three recently
identified FHM missense mutations, R583Q, D715E, and V1457L within the
1A subunit of neuronal P/Q-type Ca2+
channels. None of the mutations resulted in a nonfunctional channel as
proposed for EA-2 mutations in the
1A subunit gene. EA-2
mutations (5, 7) are believed to be incompatible with the expression of
a functional protein. In the presence of an unaffected gene, it is
therefore likely that the observed neurological phenotype in EA-2
results from a reduced activity of P/Q-type Ca2+ channels
in the central nervous system. Instead, two independent mechanisms can
affect P/Q-type currents in FHM patients: altered expression density
and changes in channel gating. Hans et al. (17) have
recently found that FHM mutations decrease or increase the density of
functional P/Q-type currents after heterologous expression in
Xenopus oocytes or mammalian cells. It is difficult to
predict if these changes of expression density also occur in vivo where, in addition to the accessory
2-
and
subunits,
1A interacts with a number of other
modulatory proteins such as G-proteins (27), calmodulin (28), and
synaptic vesicle proteins (29). Clearly, this important question can
only be addressed in animal models containing the respective mutations.
A second mechanism by which FHM mutations can affect P/Q-type Ca2+ currents is by changing channel gating. Our electrophysiological analysis provides convincing evidence that such changes also occur in three recently identified FHM mutations. Together with our previous results (16) this allows us to conclude that, irrespective of changes in expression density, this represents an elementary functional alteration underlying P/Q-type Ca2+ channel dysfunction in FHM.
As for T666M, V714A, and I1811L, all three new mutations significantly shifted the voltage dependence of activation to more negative potentials. In the absence of changes in the slope of the activation curve this must result in a more negative threshold of Ca2+ channel activation. This could lead to altered Ca2+ signaling by increasing P/Q-type Ca2+ channel activity at weak depolarizations. Two of the mutations also caused a more pronounced decrease of IBa during pulse trains, reflecting altered accumulation of channels in inactivation. This can result from either increased inactivation during the pulse or delayed recovery from inactivation between pulses. Our experiments demonstrate that it is due to slower recovery from inactivation in R583Q and faster inactivation in D715E. In V1457L decrease of IBa during the train was not different from wild type. This can be explained by the slower inactivation kinetics, which are counteracted by the slowed recovery from inactivation. Altered accumulation of channels in inactivation during rapid depolarizations could cause changes in Ca2+ influx especially during high but not during low neuronal activity. This may underlie the episodic character of FHM with attacks triggered by sensory or emotional stimuli.
In addition to the potential insight into the pathophysiology of
migraine, mutations R583Q and D715E also provide us with interesting
molecular information about channel function. As in the previously
analyzed mutant R192Q (16), R583Q eliminates a conserved positive
charge at the extracellular side of transmembrane S4-helix, which forms
part of the voltage sensor of the channel. The charge neutralization at
position 583 in IIS4 (R583Q) shifted the voltage dependence of
activation (and inactivation) to more negative potentials and slowed
recovery from inactivation. These findings indicate that not only
mutations in the putative pore region (T666M, V714A, I1811L) but also
in the S4 segments can alter
1A recovery from
inactivation. This illustrates that conformational changes of
voltage-sensing portions of
1A are involved in this process.
Mutation R583Q caused a negative shift of V0.5,act without a change in the apparent gating charge, zg (Table I). Based on a simplified model describing the gating of a channel with only two states (open and closed) (Equation 2-22 in Ref. 30; 31) a negative shift of V0.5,act suggests that this mutation decreases the conformational energy difference between the closed and open states.
By assuming a model in which the voltage sensors in all four repeats
move independently it can be predicted that Arg-583 (in IIS4) forms
part of a voltage sensor which moves over potentials close to those
causing channel opening. This is in contrast to data reported earlier
for an
1S (skeletal muscle)/
1C (cardiac muscle) chimera where this was observed for sensors in repeats I and
III but not in repeat II. Therefore this naturally occurring mutation
clearly demonstrates that voltage sensor movements vary not only
between different voltage-dependent cation channels (31) but even between different Ca2+ channel
1 subunits.
Mutation D715E is located adjacent to mutation V714A. Together with
I1811L in IVS6 these are believed to be located close to the
cytoplasmic mouth of the pore. Unlike V714A and I1811L, D715E did not
affect recovery from inactivation and prominently accelerated current
inactivation upon depolarization. These data indicate that the
cytoplasmic end of S6 helices comprise a functionally relevant region
within
1A which tightly controls the channel's inactivation properties. Although our data do not allow us to propose a
defined molecular mechanism for this process they clearly show that
even minor structural changes such as the introduction of a single side
chain methyl group in mutant D715E are sufficient to disturb this
functional domain.
The present work clearly shows that mutations in the human
CACNA1A gene alter the gating properties of neuronal
P/Q-type Ca2+ channels in all seven FHM mutants analyzed so
far. This provides a rational basis for the generation of mutant mice
containing selected mutations. Introduction of FHM mutations differing
with respect to their biophysical properties should enable
electrophysiological analysis of the consequences of altered channel
gating for neuronal Ca2+ signaling in FHM and more common
forms of migraine (15).
| |
ACKNOWLEDGEMENTS |
|---|
We thank E. Wappl and E. Emberger for help in construction of mutants and P. Dietl for critical comments on the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported in part by Fonds zur Förderung der Wissenschaftlichen Forschung Grants P-12641 (to J. S.) and P-12689 (to H. G.) and by the Österreichische Nationalbank (to J. S.), the Dr. Legerlotz Foundation, and the University of Innsbruck.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Recipient of a Hertha-Firnberg fellowship.
¶ To whom correspondence should be addressed. Tel.: 43-512-507-3164; Fax: 43-512-588-627; E-mail: joerg.striessnig@uibk.ac.at.
2 D. Kullmann, personal communication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: EA-2, episodic ataxia type 2; FHM, familial hemiplegic migraine; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; IBa, inward Ba2+ currents; V0.5, act, half-maximal voltage for activation; kact, slope factor of the curve at V0.5,act; V0.5, inact, half-maximal voltage for steady-state inactivation; kinact, slope factor of the curve at V0.5,act.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Mori, Y., Friedrich, T., Kim, M.-S., Mikami, A., Nakai, J., Ruth, P., Bosse, E., Hofmann, F., Flockerzi, V., Furuichi, T., Mikoshiba, K., Imoto, K., Tanabe, T., and Numa, S. (1991) Nature 350, 398-402[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Stea, A.,
Tomlinson, W. J.,
Soong, T. W.,
Bourinet, E.,
Dubel, S. J.,
Vincent, S. R.,
and Snutch, T. P.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
10576-10580 |
| 3. |
Westenbroek, R. E.,
Sakurai, T.,
Elliott, E. M.,
Hell, J. W.,
Starr, T. V.,
Snutch, T. P.,
and Catterall, W. A.
(1995)
J. Neurosci.
15,
6403-6418 |
| 4. |
Wheeler, D. B.,
Tsien, R. W.,
and Randall, A.
(1994)
Science
266,
828-831 |
| 5. | Ophoff, R. A., Terwindt, G. M., Vergouwe, M. N., van Eijk, R., Oefner, P. J., Hoffmann, S. M. G., Lamerdin, J. E., Mohrenweiser, H. W., Bulman, D. E., Ferrari, M., Haan, J., Lindhout, D., van Ommen, G. J. B., Hofker, M. H., Ferrari, M. D., and Frants, R. R. (1996) Cell 87, 543-552[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Yue, Q., Jen, J. C., Thwe, M. M., Nelson, S. F., and Baloh, R. W. (1998) Am. J. Med. Genet. 77, 298-301[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Denier, C.,
Ducros, A.,
Vahedi, K.,
Joutel, A.,
Thierry, P.,
Ritz, A.,
Castelnovo, G.,
Deonna, T.,
Gerard, P.,
Devoize, J. L.,
Gayou, A.,
Perrouty, B.,
Soisson, T.,
Autret, A.,
Warter, J. M.,
Vighetto, A.,
Van Bogaert, P.,
Alamovitch, S.,
Roullet, E.,
and Tournier-Lasserve, E.
(1999)
Neurology
52,
1816-1821 |
| 8. |
Jen, J.,
Yue, Q.,
Nelson, S. F., Yu, H.,
Litt, M.,
Nutt, J.,
and Baloh, R. W.
(1999)
Neurology
53,
34-37 |
| 9. | Zhuchenko, O., Bailey, J., Bonnen, P., Ashizawa, T., Stockton, D. W., Amos, C., Dobyns, W. B., Subramony, S. H., Zoghbi, H. Y., and Lee, C. C. (1997) Nat. Genet. 15, 62-69[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Yue, Q., Jen, J. C., Nelson, S. F., and Bahloh, R. W. (1997) Am. J. Hum. Genet. 61, 1078-1087[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Ducros, A., Denier, C., Joutel, A., Vahedi, K., Michel, A., Darcel, F., Madigand, M., Guerouaou, D., Tison, F., Julien, J., Hirsch, E., Chedru, F., Bisgard, C., Lucotte, G., Despres, P., Billard, C., Barthez, M. A., Ponsot, G., Bousser, M. G., and Tournier-Lasserve, E. (1999) Am. J. Hum. Genet. 64, 89-98[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Battistini, S.,
Stenirri, S.,
Piatti, M.,
Gelfi, C.,
Righetti, P. G.,
Rocchi, R.,
Giannini, F.,
Battistini, N.,
Guazzi, G. C.,
Ferrari, M.,
and Carrera, P.
(1999)
Neurology
53,
38-43 |
| 13. |
Carrera, P.,
Piatti, M.,
Stenirri, S.,
Grimaldi, L. M. E.,
Marchioni, E.,
Curcio, M.,
Righetti, P. G.,
Ferrari, M.,
and Gelfi, C.
(1999)
Neurology
53,
26-32 |
| 14. | Fletcher, C. F., Lutz, C. M., O'Sullivan, T. N., Shaughnessy, J. D., Hawkes, R., Frankel, W. N., Copeland, N. G., and Jenkins, N. A. (1996) Cell 87, 607-617[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | May, A., Ophoff, R. A., Terwindt, G. M., Urban, C., van Eijk, R., Haan, J., Diener, H. C., Lindhout, D., Frants, R. R., Sandkuijl, L. A., and Ferrari, M. D. (1995) Hum. Genet. 96, 604-608[Medline] [Order article via Infotrieve] |
| 16. |
Kraus, R. L.,
Sinnegger, M. J.,
Glossmann, H.,
Hering, S.,
and Striessnig, J.
(1998)
J. Biol. Chem.
273,
5586-5590 |
| 17. |
Hans, M.,
Luvisetto, S.,
Williams, M. E.,
Spagnolo, M.,
Urrutia, A.,
Tottene, A.,
Brust, P. L.,
Johnson, E. C.,
Harpold, M. M.,
Stauderman, K. A.,
and Pietrobon, D.
(1999)
J. Neurosci.
19,
1610-1619 |
| 18. |
Terwindt, G. M.,
Ophoff, R. A.,
Haan, J.,
Vergouwe, M. N.,
van Eijk, R.,
Frants, R. R.,
and Ferrari, M. D.
(1998)
Neurology
50,
1105-1110 |
| 19. | Diener, H. C., and May, A. (1996) Curr. Opin. Neurol. 9, 199-201[Medline] [Order article via Infotrieve] |
| 20. | Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K., and Pease, L. R. (1989) Gene (Amst.) 77, 61-68[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Grabner, M., Wang, Z., Hering, S., Striessnig, J., and Glossmann, H. (1996) Neuron 16, 207-218[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Hering, S.,
Aczel, S.,
Grabner, M.,
Döring, F.,
Berjukow, S.,
Mitterdorfer, J.,
Sinnegger, M. J.,
Striessnig, J.,
Degtiar, V. E.,
Wang, Z.,
and Glossmann, H.
(1996)
J. Biol. Chem.
271,
24471-24475 |
| 23. |
Krieg, P. A.,
and Melton, D. A.
(1984)
Nucleic Acids Res.
12,
7057-7070 |
| 24. |
Ruth, P.,
Roehrkasten, A.,
Biel, M.,
Bosse, E.,
Regulla, S.,
Meyer, H. E.,
Flockerzi, V.,
and Hofmann, F.
(1989)
Science
245,
1115-1118 |
| 25. |
Ellis, S. B.,
Williams, M. E.,
Ways, N. R.,
Brenner, R.,
Sharp, A. H.,
Leung, A. T.,
Campbell, K. P.,
McKenna, E.,
Koch, W. J.,
Hui, A.,
Schwartz, A.,
and Harpold, M. M.
(1988)
Science
241,
1661-1664 |
| 26. | Armstrong, C., and Hille, B. (1998) Neuron 20, 371-380[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Herlitze, S., Garcia, D. E., Mackie, K., Hille, B., Scheuer, T., and Catterall, W. A. (1996) Nature 380, 258-262[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Lee, A., Wong, S. T., Gallagher, D., Li, B., Storm, D. R., Scheuer, T., and Catterall, W. A. (1999) Nature 399, 155-159[CrossRef][Medline] [Order article via Infotrieve] |
| 29. |
Rettig, J.,
Sheng, Z.-H.,
Kim, D. K.,
Hodson, C. D.,
Snutch, T. P.,
and Catterall, W. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
7363-7368 |
| 30. | Hille, B. (1992) Neuron 9, 187-195[Medline] [Order article via Infotrieve] |
| 31. |
Garcia, J.,
Nakai, J.,
Imoto, K.,
and Beam, K. G.
(1997)
Biophys. J.
72,
2515-2523 |
This article has been cited by other articles:
![]() |
H. Khosravani and G. W. Zamponi Voltage-gated calcium channels and idiopathic generalized epilepsies. Physiol Rev, July 1, 2006; 86(3): 941 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pietrobon Migraine: New Molecular Mechanisms Neuroscientist, August 1, 2005; 11(4): 373 - 386. [Abstract] [PDF] |
||||
![]() |
J. Wan, R. Khanna, M. Sandusky, D. M. Papazian, J. C. Jen, and R. W. Baloh CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics Neurology, June 28, 2005; 64(12): 2090 - 2097. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Barrett, Y.-Q. Cao, and R. W. Tsien Gating Deficiency in a Familial Hemiplegic Migraine Type 1 Mutant P/Q-type Calcium Channel J. Biol. Chem., June 24, 2005; 280(25): 24064 - 24071. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hemara-Wahanui, S. Berjukow, C. I. Hope, P. K. Dearden, S.-B. Wu, J. Wilson-Wheeler, D. M. Sharp, P. Lundon-Treweek, G. M. Clover, J.-C. Hoda, et al. A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activation PNAS, May 24, 2005; 102(21): 7553 - 7558. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tottene, F. Pivotto, T. Fellin, T. Cesetti, A. M. J. M. van den Maagdenberg, and D. Pietrobon Specific Kinetic Alterations of Human CaV2.1 Calcium Channels Produced by Mutation S218L Causing Familial Hemiplegic Migraine and Delayed Cerebral Edema and Coma after Minor Head Trauma J. Biol. Chem., May 6, 2005; 280(18): 17678 - 17686. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Q. Cao and R. W. Tsien Effects of familial hemiplegic migraine type 1 mutations on neuronal P/Q-type Ca2+ channel activity and inhibitory synaptic transmission PNAS, February 15, 2005; 102(7): 2590 - 2595. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mullner, L. A. M. Broos, A. M. J. M. van den Maagdenberg, and J. Striessnig Familial Hemiplegic Migraine Type 1 Mutations K1336E, W1684R, and V1696I Alter Cav2.1 Ca2+ Channel Gating: EVIDENCE FOR {beta}-SUBUNIT ISOFORM-SPECIFIC EFFECTS J. Biol. Chem., December 10, 2004; 279(50): 51844 - 51850. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. McRory, J. Hamid, C. J. Doering, E. Garcia, R. Parker, K. Hamming, L. Chen, M. Hildebrand, A. M. Beedle, L. Feldcamp, et al. The CACNA1F Gene Encodes an L-Type Calcium Channel with Unique Biophysical Properties and Tissue Distribution J. Neurosci., February 18, 2004; 24(7): 1707 - 1718. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Stotz, S. E. Jarvis, and G. W. Zamponi Functional roles of cytoplasmic loops and pore lining transmembrane helices in the voltage-dependent inactivation of HVA calcium channels J. Physiol., January 15, 2004; 554(2): 263 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Alonso, J. Barros, A. Tuna, J. Coelho, J. Sequeiros, I. Silveira, and P. Coutinho Phenotypes of Spinocerebellar Ataxia Type 6 and Familial Hemiplegic Migraine Caused by a Unique CACNA1A Missense Mutation in Patients From a Large Family Arch Neurol, April 1, 2003; 60(4): 610 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tottene, T. Fellin, S. Pagnutti, S. Luvisetto, J. Striessnig, C. Fletcher, and D. Pietrobon Familial hemiplegic migraine mutations increase Ca2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons PNAS, October 1, 2002; 99(20): 13284 - 13289. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Kullmann The neuronal channelopathies Brain, June 1, 2002; 125(6): 1177 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Wappl, A. Koschak, M. Poteser, M. J. Sinnegger, D. Walter, A. Eberhart, K. Groschner, H. Glossmann, R. L. Kraus, M. Grabner, et al. Functional Consequences of P/Q-type Ca2+ Channel Cav2.1 Missense Mutations Associated with Episodic Ataxia Type 2 and Progressive Ataxia J. Biol. Chem., February 22, 2002; 277(9): 6960 - 6966. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jen, J. Wan, M. Graves, H. Yu, A. F. Mock, C. J. Coulin, G. Kim, Q. Yue, D. M. Papazian, and R. W. Baloh Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission Neurology, November 27, 2001; 57(10): 1843 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ducros, C. Denier, A. Joutel, M. Cecillon, C. Lescoat, K. Vahedi, F. Darcel, E. Vicaut, M.-G. Bousser, and E. Tournier-Lasserve The Clinical Spectrum of Familial Hemiplegic Migraine Associated with Mutations in a Neuronal Calcium Channel N. Engl. J. Med., July 5, 2001; 345(1): 17 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Wappl, J. Mitterdorfer, H. Glossmann, and J. Striessnig Mechanism of Dihydropyridine Interaction with Critical Binding Residues of L-type Ca2+ Channel alpha 1 Subunits J. Biol. Chem., April 13, 2001; 276(16): 12730 - 12735. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Berjukow, R. Marksteiner, S. Sokolov, R. G. Weiss, E. Margreiter, and S. Hering Amino Acids in Segment IVS6 and beta -Subunit Interaction Support Distinct Conformational Changes during Cav2.1 Inactivation J. Biol. Chem., May 11, 2001; 276(20): 17076 - 17082. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Stotz and G. W. Zamponi Identification of Inactivation Determinants in the Domain IIS6 Region of High Voltage-activated Calcium Channels J. Biol. Chem., August 24, 2001; 276(35): 33001 - 33010. [Abstract] [Full Text] [PDF] |
||||
| ||||||||